Home › Funds › Lynx1 Capital Management LP › IMCR
Lynx1 Capital Management LP position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
Lynx1 Capital Management LP reported holding 14,300 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$433K, representing 0.07% of its reported portfolio and ranking #20 among its reported holdings. Lynx1 Capital Management LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Lynx1 Capital Management LP's IMCR position evolved
Lynx1 Capital Management LP first disclosed a stake in IMCR in Q3 2026 at 14,300 shares (US$433K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 14.30K | $433.15K | New |
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 28 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), TANG CAPITAL MANAGEMENT LLC (US$87.4M), Bellevue Group AG (US$68.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $147.51M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 2.88M sh · $87.36M · Q3 2026
- Bellevue Group AG 2.26M sh · $68.59M · Q3 2026
- Caligan Partners LP 1.67M sh · $50.65M · Q3 2026
- Kynam Capital Management, LP 1.38M sh · $41.65M · Q3 2026
- BVF INC/IL 1.23M sh · $37.28M · Q3 2026
- MPM BioImpact LLC 1.20M sh · $36.45M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.14M sh · $34.41M · Q3 2026
- Trails Edge Capital Partners, LP 1.06M sh · $32.21M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 928.00K sh · $28.11M · Q3 2026
- BRAIDWELL LP 906.12K sh · $27.45M · Q3 2026
- Vestal Point Capital, LP 850.00K sh · $25.75M · Q3 2026
More on Lynx1 Capital Management LP
FAQ
How long has Lynx1 Capital Management LP held IMCR?
Lynx1 Capital Management LP has disclosed IMCR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Lynx1 Capital Management LP's current position in IMCR?
As of Q3 2026, Lynx1 Capital Management LP holds 14.30K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $433.15K, representing 0.07% of its reported portfolio and ranking #20.
Has Lynx1 Capital Management LP been buying or selling IMCR?
In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP newly opened its position in IMCR.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, Bellevue Group AG, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.